已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Cost-effectiveness analysis of preloaded versus non-preloaded Descemet membrane endothelial keratoplasty for the treatment of Fuchs endothelial corneal dystrophy in an academic centre

医学 眼科 后弹力膜 角膜移植 角膜
作者
Myriam Böhm,Pia Leon,Adam Wylęgała,Stephan Ong Tone,Tracy Condron,Myriam Böhm
出处
期刊:British Journal of Ophthalmology [BMJ]
卷期号:106 (7): 914-922 被引量:10
标识
DOI:10.1136/bjophthalmol-2020-317536
摘要

To determine the cost-effectiveness of preloaded Descemet membrane endothelial keratoplasty (pDMEK) versus non-preloaded DMEK (n-pDMEK) for the treatment of Fuchs endothelial corneal dystrophy (FECD).From a societal and healthcare perspective, this retrospective cost-effectiveness analysis analysed a cohort of 58 patients with FECD receiving pDMEK (n=38) or n-pDMEK (n=30) from 2016 to 2018 in the Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, USA. Exclusion criteria were previous ocular surgeries (other than uncomplicated cataract surgery), including other keratoplasty procedures, ocular pathological conditions as glaucoma, amblyopia, laser treatments, or any retinal or corneal disease. The main outcome parameters were the incremental cost-utility ratio (ICUR) and net monetary benefit (NMB).pDMEK was less costly compared with n-pDMEK (healthcare: $13 886 vs $15 329; societal: $20 805 vs $22 262), with a slighter greater utility (QALY 0.6682 vs QALY 0.6640) over a time horizon of 15 years. pDMEK offered a slightly higher clinical effectiveness (+0.0042 QALY/patient) at a lower cost (healthcare: -$1444 per patient; societal: -$1457 per patient) in improving visual acuity in this cohort of patients with FECD. pDMEK achieved a favourable ICUR and NMB compared with n-pDMEK. Based on sensitivity analyses performed, the economic model was robust.From the societal and healthcare perspective, pDMEK was less costly and generated comparable utility values relative to n-pDMEK. Therefore, pDMEK appears to be cost-effective and cost saving with respect to n-pDMEK. Further long-term follow-up data are needed to confirm these findings.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Micheal完成签到 ,获得积分10
刚刚
Lucas应助科研通管家采纳,获得10
1秒前
研友_Z14Yln应助科研通管家采纳,获得10
1秒前
Phosphene应助科研通管家采纳,获得10
1秒前
2秒前
morena应助科研通管家采纳,获得10
2秒前
科研通AI2S应助科研通管家采纳,获得10
2秒前
科研通AI2S应助科研通管家采纳,获得10
2秒前
2秒前
Demi_Ming完成签到,获得积分10
2秒前
澄子完成签到 ,获得积分10
3秒前
她说爱是奢侈品完成签到,获得积分10
4秒前
yue完成签到,获得积分10
5秒前
naomi完成签到 ,获得积分10
7秒前
deeferf完成签到 ,获得积分10
7秒前
王小明完成签到 ,获得积分20
7秒前
8秒前
沉静一刀完成签到 ,获得积分10
8秒前
8秒前
10秒前
10秒前
Ava应助南风采纳,获得10
11秒前
LRxxx完成签到 ,获得积分10
12秒前
柳梦完成签到 ,获得积分10
13秒前
wyy发布了新的文献求助10
15秒前
甜甜甜完成签到 ,获得积分10
15秒前
zhong241发布了新的文献求助10
16秒前
YY完成签到 ,获得积分10
16秒前
aaa完成签到 ,获得积分10
18秒前
文献文献完成签到 ,获得积分10
19秒前
ranj完成签到,获得积分10
19秒前
21秒前
wangfang0228完成签到 ,获得积分10
21秒前
23秒前
南风发布了新的文献求助10
25秒前
香蕉觅云应助笨笨的傲芙采纳,获得10
26秒前
26秒前
李健应助王小明采纳,获得10
28秒前
zhong241完成签到,获得积分10
28秒前
111发布了新的文献求助10
29秒前
高分求助中
The ACS Guide to Scholarly Communication 2500
Microlepidoptera Palaearctica, Volumes 1 and 3 - 13 (12-Volume Set) [German] 1122
Pharmacogenomics: Applications to Patient Care, Third Edition 1000
TM 5-855-1(Fundamentals of protective design for conventional weapons) 1000
Ethnicities: Media, Health, and Coping 700
Ожившие листья и блуждающие цветы. Практическое руководство по содержанию богомолов [Alive leaves and wandering flowers. A practical guide for keeping praying mantises] 500
Development of a new synthetic process for the synthesis of (S)-methadone and (S)- and (R)-isomethadone as NMDA receptor antagonists for the treatment of depression 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3090828
求助须知:如何正确求助?哪些是违规求助? 2743117
关于积分的说明 7572351
捐赠科研通 2393700
什么是DOI,文献DOI怎么找? 1269405
科研通“疑难数据库(出版商)”最低求助积分说明 614337
版权声明 598756